Advances in heart transplantation: The year in review

Journal of Heart and Lung Transplantation

Volumn 30, Issue 3, 2011, Pages 241-246

  Shah, Keyur B ^a   Parameshwar, Jayan ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN; HYPOXIA INDUCIBLE FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ARTICLE; ASSISTED CIRCULATION; CARDIAC ALLOGRAFT VASCULOPATHY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; GRAFT REJECTION; GRAFT SURVIVAL; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BIOMEDICAL RESEARCH; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79551682681     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2010.10.013     Document Type: Article

References (42)

1. M.R. Costanzo, M.R. Costanzo, and A. Dipchand The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients J Heart Lung Transplant 29 2010 914 956
2. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010 J Heart Lung Transplant 29 2010 717 727
3. C.F. Bulcao, K.M. D'Souza, and R. Malhotra Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction J Heart Lung Transplant 29 2010 346 351
4. L. Yang, and T. Yu Prolonged donor heart preservation with pinacidil: the role of mitochondria and the mitochondrial adenosine triphosphate-sensitive potassium channel J Thorac Cardiovasc Surg 139 2010 1057 1063
5. A. Nakao, D.J. Kaczorowski, and Y. Wang Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both J Heart Lung Transplant 29 2010 544 553
6. S. Repse, S. Pepe, J. Anderson, C. McLean, and F.L. Rosenfeldt Cardiac reanimation for donor heart transplantation after cardiocirculatory death J Heart Lung Transplant 29 2010 747 755
7. M. Hirota, K. Ishino, T. Tedoriya, and S. Sano Post-mortem tissue-type plasminogen activator preserves graft function of hearts harvested from non-pre-treated non-heart-beating donors J Heart Lung Transplant 29 2010 888 893
8. J.N. Nativi, A.G. Kfoury, and C. Myrick Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation J Heart Lung Transplant 29 2010 235 239
9. T. Komoda, T. Drews, R. Hetzer, and H.B. Lehmkuhl New prioritization of heart transplant candidates on mechanical circulatory support in an era of severe donor shortage J Heart Lung 29 2010 989 996
10. J. Stehlik, D.S. Feldman, and R.N. Brown Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis J Heart Lung Transplant 29 2010 291 298
11. T.P. Singh, M.M. Givertz, M. Semigran, D. Denofrio, F. Costantino, and K. Gauvreau Socioeconomic position, ethnicity, and outcomes in heart transplant recipients Am J Cardiol 105 2010 1024 1029
12. J.H. Shuhaiber, J. Moore, and D.B. Dyke The effect of transplant center volume on survival after heart transplantation: a multicenter study J Thorac Cardiovasc Surg 139 2010 1064 1069
13. R.S. Wu, S. Gupta, R.N. Brown, C.W. Yancy, J.W. Wald, and P. Kaiser Clinical outcomes after cardiac transplantation in muscular dystrophy patients J Heart Lung Transplant 29 2010 432 438
14. N. Uriel, A. Vainrib, and U.P. Jorde Mediastinal radiation and adverse outcomes after heart transplantation J Heart Lung Transplant 29 2010 378 381
15. T. Karamlou, J. Hirsch, and K. Welke A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation J Thorac Cardiovasc Surg 140 2010 161 168
16. D.A. Bull, B.B. Reid, and C.H. Selzman The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation J Thorac Cardiovasc Surg 140 2010 169 173
17. N.G. Smedira, K.J. Hoercher, and D.Y. Yoon Bridge to transplant experience: factors influencing survival to and after cardiac transplant J Thorac Cardiovasc Surg 139 2010 1295 1305
18. J.H. Shuhaiber, K. Hur, and R. Gibbons The influence of preoperative use of ventricular assist devices on survival after heart transplantation: propensity score matched analysis BMJ 340 2010 c392
19. R. John, F.D. Pagani, and Y. Naka Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
20. A.C. Alba, V. Rao, and H.J. Ross Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients J Heart Lung Transplant 29 2010 125 128
21. R. John, K. Liao, F. Kamdar, P. Eckman, A. Boyle, and M. Colvin-Adams Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices J Thorac Cardiovasc Surg 140 2010 447 452
22. L. Jun, Z. Kailun, and X. Aini Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation J Heart Lung Transplant 29 2010 461 470
23. M.L.K. de Bold, A. Etchepare, A. Martinuk, and A.J. de Bold Cardiac hormones ANF and BNP modulate proliferation in the unidirectional mixed lymphocyte reaction J Heart Lung Transplant 29 2010 323 326
24. X.L. Li, S. Mnoret, and S. Bezie Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance J Immunol 185 2010 823 833
25. C. LeGuern, Y. Akiyama, and S. Germana Intracellular MHC class II controls regulatory tolerance to allogeneic transplants J Immunol 184 2010 2394 2400
26. J.A. Kobashigawa, K.K. Kiyosaki, and J.K. Patel Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes J Heart Lung Transplant 29 2010 504 508
27. L. Gullestad, M. Iversen, and S. Mortensen Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial Transplantation 89 2010 864 872
28. E. Gude, L. Gullestad, and S. Arora Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation J Heart Lung Transplant 29 2010 641 647
29. S.O. Syrjl, M.A.I. Kernen, and R. Tuuminen Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat J Heart Lung Transplant 29 2010 1047 1057
30. B. Mahesh, H. Leong, K.S. Nair, A. McCormack, P. Sarathchandra, and M.L. Rose Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts Transplantation 90 2010 4 13
31. D.S. Nath, H. Ilias Basha, and V. Tiriveedhi Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy J Heart Lung Transplant 29 2010 1277 1285
32. A.I. Nyknen, H. Sandelin, and R. Krebs Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts Circulation 121 2010 1413 1422
33. M.A.I. Kernen, A.I. Nyknen, and R. Krebs Cardiomyocyte-targeted HIF-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat J Heart Lung Transplant 29 2010 1058 1066
34. H. Kosuge, T. Ishihara, and G. Haraguchi Treatment with telmisartan attenuates graft arteriosclerosis in murine cardiac allografts J Heart Lung Transplant 29 2010 562 567
35. E.L. Moseley, C. Atkinson, L.D. Sharples, J. Wallwork, and M.J. Goddard Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy J Heart Lung Transplant 29 2010 417 423
36. G. Korosoglou, N. Riedle, and M. Erbacher Quantitative myocardial blush grade for the detection of cardiac allograft vasculopathy Am Heart J 159 2010 643 651
37. M.X. Pham, J.J. Teuteberg, and A.G. Kfoury Gene-expression profiling for rejection surveillance after cardiac transplantation N Engl J Med 362 2010 1890 1900
38. S. Koestenbauer, P. Stiegler, and V. Stadlbauer Myeloperoxidase and carbonyl proteins: Promising markers for non-invasive monitoring of graft rejection after heart transplantation J Heart Lung Transplant 2010 10.1016/j.healun.2010.05.020
39. G.M. Pieper, A. Shah, L. Harmann, B.C. Cooley, I.A. Ionova, and R.Q. Migrino Speckle-tracking 2-dimensional strain echocardiography: A new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation J Heart Lung Transplant 29 2010 1039 1046
40. P.C. Patel, S.C. Reimold, and F.G. Araj Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients J Heart Lung Transplant 2010 10.1016/j.healun.2010.05.008
41. F. Haddad, T. Deuse, and M. Pham Changing trends in infectious disease in heart transplantation J Heart Lung Transplant 29 2010 306 315
42. H.L. Godoy, C.M. Guerra, and R.F. Viegas Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease J Heart Lung Transplant 29 2010 286 290